Imaging3, Inc. (IMGG) to Implement Stock Buyback Plan

Mar. 24, 2011 11:11 AM ETIMGG
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Contributor Since 2008

QualityStocks ( assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with companies that have huge potential to succeed in the short and long-term future. QualityStocks provides investor relations services to publicly traded companies in exchange for compensation. The content we provide via Seeking Alpha may be part of our efforts to widen a client’s exposure. To read our full disclaimer, visit

Located in Burbank, California, Imaging3 has quickly made a name for itself as a leading provider of medical imaging devices. Imaging3 is unique in that the company produces 3D medical images of virtually any part of the human body is real-time. Today, the young corporation announced a management stock buyback plan.

Effective immediately, the Board of Directors of Imaging3 has approved the repurchase of up to 5% of the outstanding Common Stock. The stock will be purchased by various members of the company’s own management team.

The stocks will be purchased from time to time at prevailing market prices through open market or unsolicited negotiated transactions which are dependent upon market conditions in accordance with Rule 10b-18 and the reporting of other requirements of section 16 of the Securities Exchange Act of 1934, as amended. The repurchase program is expected to continue over the next 12 months unless extended or shortened by the Board of Directors.

Leading the way at Imaging3 is Dean James who serves as the company’s Chairman and CEO. Commenting on what effect this program may have on the future of Imaging3, James was quoted as saying, “Our open market purchases by management over the course of the next year reflects management’s continued confidence in Imaging3′s business strategy and growth prospects as we continue the FDA approval process. Based on current market prices, we believe the repurchase program is in the best interests of our shareholders.”

To learn more about the company as a whole, visit their website at:

Please see disclaimer on QualityStocks website:

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.